Conclusion: Saffron demonstrates promise in improving ADHD symptoms, with an acceptable safety profile. Future well-designed multicentral studies are suggested.
PubMed 37864351 ↗Saffron
Also known as Crocus Sativus, Affron
The short answer. More people than not who report on Saffron say it helped (62% of 223). It is most often used for mood: 92% of 165 reports say that improved. It is well studied — 88 meta-analyses on PubMed. The most common complaint is headache.
From 421 mentions in total — the rest didn't say how it went and aren't counted.
What Saffron does, according to users
Of the people who reported each effect, the share who said it got better.
3 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 88 meta-analyses on PubMed ↗ · 119 randomized trials ↗
Conclusion: Research conducted so far provides initial support for the use of saffron for the treatment of mild-to-moderate depression. Further research is required to expand our understanding of the role and actions of saffron in major depression.
PubMed 25384672 ↗Conclusion: Saffron could be a potential SSRI alternative to reduce depressive and anxiety symptoms with fewer adverse events. Further research with larger sample sizes and in diverse populations is warranted to validate these findings and explore potential moderators of treatment response.
PubMed 38913392 ↗Conclusion: Saffron was non-inferior to conventional drugs for treating cognitive disorders, depression, anxiety, ADHD, and OCD, and it exhibited good tolerance with few side effects. Saffron may exert protective roles for neurological and psychiatric disorders and represents a relatively favorable and safe treatment.
PubMed 38424688 ↗49 human trials on ClinicalTrials.gov test Saffron — 26 completed, 2 recruiting now. See all on ClinicalTrials.gov ↗
- A Clinical Study to Assess the Effect of a Dietary Supplement on Menstrual Cycle Symptoms · Premenstrual Syndrome, Menstrual Pain · 2025
- Efficacy of Satisens® in Reducing Emotional Eating · Emotional Eating, Overweight or Obesity · 2026
- Effects of a Standardised Saffron Extract Supplementation on Symptoms Associated With Perimenopause in Healthy Women · Perimenopausal Disorder · 2026
Reports to the FDA
Adverse-event reports about supplements containing it, submitted to the US FDA by consumers and doctors.
15 reports name a product containing Saffron (2012–2025); 7 involved hospitalization or worse. Most often reported:
- Pruritus · 5
- Urticaria · 2
- Rash · 2
- Hepatotoxicity · 1
- Pyrexia · 1
- Acute coronary syndrome · 1
A report doesn't prove the supplement caused the problem — many products contain several ingredients, and these counts can't tell you how often it happens. Source: FDA CAERS ↗ · raw reports (openFDA) ↗.
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
NIH has funded 1 research project with Saffron in the title, $604,784 in total (2024–2025). NIH RePORTER ↗
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“I just sneak some into whatever soup we are having. I honestly think it has made a huge difference.”
“I tried so many things for depression like saffron rhodiola tyrosine omega 3 methylfolate B12 taurine theanine NAC inositol b complex magnesium nothing helps it.”
“After two weeks of taking I started feeling amazing, the depression was almost no existent anymore. But now its back again.”
“Within a week I just felt…normal. Not a stimulant, not a relaxant, just…okay, balanced, content, slightly more motivated, and mostly all of my lifelong meralgia paresthetica in my thighs went away.”
Top discussions (5)
Saffron compared
Other options for mood
Sources
- User reports: 421 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- NIH RePORTER ↗
- US Food and Drug Administration: CAERS adverse-event reports ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate